NL-OMON36575
Withdrawn
Not Applicable
A search for novel therapeutic targets and biomarkers in patients with Systemic Lupus Erythematosus - New biomarkers for disease activity and treatment in SLE
niversitair Medisch Centrum Utrecht0 sites75 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- SLE
- Sponsor
- niversitair Medisch Centrum Utrecht
- Enrollment
- 75
- Status
- Withdrawn
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients full\-filling the ACR criteria for systemic lupus erythematosus
- •Controles: 18 years or older
Exclusion Criteria
- •Patients: patients with proven other auto\-immune disorders, pregnancy and malignancy
- •Controls: a history or presence of auto\-immune disease and current use of immunosupressants or pregnancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Discovery of proteins that differentiate health and disease around dental implantsPeri-ImplantitisE06.780.346.593RBR-99xvpphniversidade Estadual de Maringá
Recruiting
Not Applicable
molecular based analysis and novel therapies development of chronic myelocytic leukemiachronic myelocytic leukemiaJPRN-UMIN000015409Keio University School of Medicine, Division of Hematology200
Recruiting
Not Applicable
Search of a new tumor marker and examination of usefulness by multi-institutinal studyBreast cancer, Thyroid cancer, Esophageal cancer, Gastric cancer, Colon cancer, Liver cancer, Biliary cancer, Pancreatic cancerJPRN-UMIN000014530Toho Univerisity300
Recruiting
Not Applicable
Biomarker discovery and development of therapy for aortic aneurysmAortic aneurysmJPRN-UMIN000010927Yokohama City University Graduate School of Medicine150
Completed
Not Applicable
Research for new biomarker about diagnosis and evaluation of disease condition for inflammatory bowel disease (IBD).Inflammatory bowel diseaseJPRN-UMIN000017831Kyoto Prefectural University of Medicine400